189 related articles for article (PubMed ID: 23568857)
1. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1278-303. PubMed ID: 23568857
[TBL] [Abstract][Full Text] [Related]
2. The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death.
De Clercq E
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146783
[TBL] [Abstract][Full Text] [Related]
3. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.
De Clercq E
Antiviral Res; 2007 Jul; 75(1):1-13. PubMed ID: 17116336
[TBL] [Abstract][Full Text] [Related]
4. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
5. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
Duraffour S; Snoeck R; Krecmerová M; van Den Oord J; De Vos R; Holy A; Crance JM; Garin D; De Clercq E; Andrei G
Antimicrob Agents Chemother; 2007 Dec; 51(12):4410-9. PubMed ID: 17893157
[TBL] [Abstract][Full Text] [Related]
6. The Holý Trinity: the acyclic nucleoside phosphonates.
De Clercq E
Adv Pharmacol; 2013; 67():293-316. PubMed ID: 23886004
[TBL] [Abstract][Full Text] [Related]
7. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
8. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
De Clercq E
Biochem Pharmacol; 2011 Jul; 82(2):99-109. PubMed ID: 21501598
[TBL] [Abstract][Full Text] [Related]
9. An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.
De Clercq E
Acta Pharm Sin B; 2015 Nov; 5(6):520-43. PubMed ID: 26713268
[No Abstract] [Full Text] [Related]
10. Dancing with chemical formulae of antivirals: a personal account.
De Clercq E
Biochem Pharmacol; 2013 Sep; 86(6):711-25. PubMed ID: 23876344
[TBL] [Abstract][Full Text] [Related]
11. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
De Clercq E; Holý A
Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.
Lebeau I; Andrei G; Krecmerová M; De Clercq E; Holy A; Snoeck R
Antimicrob Agents Chemother; 2007 Jun; 51(6):2268-73. PubMed ID: 17420214
[TBL] [Abstract][Full Text] [Related]
13. Acyclic nucleoside phosphonates with a branched 2-(2-phosphonoethoxy)ethyl chain: efficient synthesis and antiviral activity.
Hocková D; Holý A; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem; 2011 Aug; 19(15):4445-53. PubMed ID: 21745746
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
[TBL] [Abstract][Full Text] [Related]
15. Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections.
De Clercq E
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960679
[TBL] [Abstract][Full Text] [Related]
16. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
De Clercq E
Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
[TBL] [Abstract][Full Text] [Related]
17. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
Andrei G; Topalis D; De Schutter T; Snoeck R
Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
[TBL] [Abstract][Full Text] [Related]
18. Versatile synthesis of oxime-containing acyclic nucleoside phosphonates--synthetic solutions and antiviral activity.
Solyev PN; Jasko MV; Kleymenova AA; Kukhanova MK; Kochetkov SN
Org Biomol Chem; 2015 Nov; 13(44):10946-56. PubMed ID: 26383895
[TBL] [Abstract][Full Text] [Related]
19. Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.
De Clercq E
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):21-43. PubMed ID: 15482100
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
Zídek Z; Potmesil P; Holý A
Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
